Home / INKA2 Knockout Cell Lines

INKA2 Knockout Cell Lines

Gene: INKA2

Official Full Name: inka box actin regulator 2provided by HGNC

Gene Summary: Enables protein kinase binding activity. Located in nucleolus and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO16923 INKA2 Knockout cell line (HeLa) Human INKA2 1:3~1:6 Negative Online Inquiry
KO16924 INKA2 Knockout cell line (HCT 116) Human INKA2 1:2~1:4 Negative Online Inquiry
KO16925 INKA2 Knockout cell line (HEK293) Human INKA2 1:3~1:6 Negative Online Inquiry
KO16926 INKA2 Knockout cell line (A549) Human INKA2 1:3~1:4 Negative Online Inquiry

Background

INKA2 Gene Knockout Cell Lines are specifically engineered mammalian cell lines that have undergone targeted gene disruption to elucidate the function of the INKA2 gene. These knockout models provide invaluable tools for studying gene function and its implications in various biological pathways. Utilizing CRISPR-Cas9 technology, our INKA2 cell lines precisely excise the INKA2 gene, allowing researchers to investigate the resulting phenotypic and molecular changes in cellular processes.

The primary function of these cell lines lies in their role as a stable platform for functional genomics and drug discovery. By selectively knocking out the INKA2 gene, scientists can examine its contribution to critical cellular processes such as cell proliferation, apoptosis, and differentiation. This understanding is particularly significant in cancer biology, where the INKA2 gene may play a role in tumorigenesis and therapeutic resistance.

INKA2 Gene Knockout Cell Lines offer distinct advantages over traditional cell models. They provide a homogeneous and reproducible system, minimizing variability often seen in primary cell cultures. Additionally, the use of CRISPR-Cas9 not only ensures precise genomic alterations but also allows for quicker establishment of knockout clones compared to older techniques like zinc-finger nucleases or siRNA approaches.

For researchers and clinicians, the availability of INKA2 knockout models is a gateway to new insights, enabling targeted therapeutic strategies and biomarker discovery. The ability to study the effects of INKA2 loss provides opportunities for innovative research into potential treatments for diseases associated with dysregulated gene expression.

Furthermore, our company prides itself on its expertise in molecular biology and cell line development, ensuring that our products meet rigorous scientific standards and provide reliable results. With a commitment to advancing research and a robust portfolio of biological products, we are dedicated to supporting the scientific community in their quest for knowledge and innovation.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.